Company facts
- Headquarters
- South San Francisco, California
- Most recent report
- 10-Q, filed Nov 4, 2026
- Incorporated
- Delaware
- Filings on record
- 353 filings
- On EDGAR
- CIK 1858848
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 8 of 22
News 8 of 54
Prospectuses and Registrations 8 of 22
- S-8 Registration statement for an employee plan Aug 5, 2026
- S-8 Registration statement for an employee plan Feb 3, 2026
- 424B5 Prospectus supplement for an offering Dec 12, 2025
- 424B5 Prospectus supplement for an offering Dec 11, 2025
- S-3 Shelf registration statement Mar 21, 2025
- 424B5 Prospectus supplement for an offering Mar 4, 2025
- 424B5 Prospectus supplement for an offering Mar 3, 2025
- 424B3 Prospectus supplement for an offering Mar 3, 2025
Proxies 8 of 14
- DEFA14A Extra proxy material Oct 23, 2026
- DEF 14A Proxy statement for a shareholder vote Oct 23, 2026
- PRE 14A Preliminary proxy statement Oct 13, 2026
- DEFA14A Extra proxy material Apr 16, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 16, 2026
- DEFA14A Extra proxy material Apr 17, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2025
- DEFA14A Extra proxy material Apr 17, 2024
Ownership 8 of 212
- 4 Insider reported a trade Sep 11, 2026
- 4 Insider reported a trade Sep 11, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 24, 2026
- 4 Insider reported a trade Aug 17, 2026
- 4 Insider reported a trade Aug 17, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- 3 Insider reported their initial holding Jul 14, 2026
Other 8 of 29
- ARS Annual report sent to shareholders Apr 16, 2026
- UPLOAD Comment letter from SEC staff Sep 10, 2025
- CORRESP Reply to SEC staff Sep 4, 2025
- UPLOAD Comment letter from SEC staff Aug 26, 2025
- ARS Annual report sent to shareholders Apr 17, 2025
- EFFECT Notice that a registration became effective Mar 31, 2025
- CORRESP Reply to SEC staff Mar 27, 2025
- UPLOAD Comment letter from SEC staff Mar 26, 2025
Everything here comes from Tenaya Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.